Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-03 Option Award | 2025-02-04 4:11 pm | N/A 2035-02-03 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 44,400 | $0 | 44,400 (Direct) | View |
| 2024-12-16 Exercise | 2024-12-18 4:51 pm | N/A 2024-12-18 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 381 | $0 | 381 (Direct) | View |
| 2024-12-16 Exercise | 2024-12-18 4:51 pm | N/A N/A | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 381 | $4.41 | 381 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 4:13 pm | N/A 2024-09-30 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 29,800 | $0 | 29,800 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 06:01 am | N/A 2034-02-01 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 30,142 | $0 | 30,142 (Direct) | View |
Ownership | 2023-06-07 9:53 pm | N/A 2027-12-27 | Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer | 0 | $0 | 90,299 (Direct) | View |